YourLawyer.com® 1-800-LAW-INFO (1-800-529-4636)
Parker Waichman Alonso LLP Headlines by Topic
Tysabri
CORRECTION: MULTIPLE SCLEROSIS DRUG (TYSABRI) MAY HAVE BEEN RESPONSIBLE FOR FOURTH CASE OF RARE BRAIN DISEASE
Jun 4, 2005 | www.Newsinferno.com
Yesterday, we reported that the FDA had been informed by Biogen Idec Inc. that a fourth person may have died from a rare and often fatal brain...
MULTIPLE SCLEROSIS DRUG (TYSABRI) MAY HAVE BEEN RESPONSIBLE FOR FOURTH DEATH FROM RARE BRAIN DISEASE
Jun 3, 2005 | www.Newsinferno.com
The FDA has been informed by Biogen Idec Inc. that a fourth person may now have died from a rare brain disease known as progressive multifocal...
Warning Didn't Slow Approval of MS Drug
Mar 2, 2005 | Los Angeles Times
A multiple sclerosis drug pulled off the market after a patient died was approved by the Food and Drug Administration even though a prominent...
Makers Take MS Drug Tysabri Off Market After Death
Mar 1, 2005 | AP
The makers of Tysabri, a new drug used to treat multiple sclerosis, said yesterday that they are voluntarily suspending sales of the drug because one...
Biogen, Elan Voluntarily Withdraw Tysabri
Feb 28, 2005 | AP
Biogen Idec Inc. and Elan Corp. announced Monday they have voluntarily withdrawn a recently approved drug used to treat multiple sclerosis after one...
Biogen, Elan Halt MS Drug After Patient Death
Feb 28, 2005 | AP
Biogen Idec (BIIB) and Elan Corp. Plc (ELN) on Monday suspended sales of their much-heralded new multiple sclerosis drug after a patient died from a...
BIOGEN IDEC AND ELAN ANNOUNCE VOLUNTARY SUSPENSION OF TYSABRI
Feb 28, 2005 | www.biogen.com
Biogen Idec (NASDAQ: BIIB) and Elan Corporation, plc (NYSE: ELN) announced today a voluntary suspension in the marketing of TYSABRI® (natalizumab), a...
Suspended Marketing of Tysabri (natalizumab)
Feb 28, 2005 | www.fda.gov
FDA is issuing this public health advisory to inform patients and health care providers about the suspended marketing of Tysabri (natalizumab) due to...
FDA Issues Public Health Advisory on Tysabri, a New Drug for MS
Feb 28, 2005 | www.fda.gov
The Food and Drug Administration (FDA) today issued a public health advisory to inform patients and health care providers about the suspended...
Tysabri
